Vanda Pharmaceuticals (VNDA) Tops Q3 EPS by 35c
Tweet
Share
E-mailGet Alerts VNDA Hot Sheet
Price: $5.23 +0.19%
Financial Fact:
Net income (loss): -430K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Net income (loss): -430K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q3 EPS of ($0.04), $0.35 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $14.8 million versus the consensus estimate of $12.2 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is Treasury selloff a major issue for stock market bulls?
- UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
- Securitize Corp (SECZ) PT Lowered to $10 at Benchmark as Stock Plummets Post Q2 Earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
